Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
Titel:
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
Auteur:
Aldoss, Ibrahim Roloff, Gregory W. Faramand, Rawan Kopmar, Noam E. Lin, Chenyu Advani, Anjali S. Dekker, Simone E. Gupta, Vishal K. O'Connor, Timothy E. Jeyakumar, Nikeshan Muhsen, Ibrahim N. Valtis, Yannis Zhang, Amy Miller, Katharine Sutherland, Katherine Dykes, Kaitlyn C. Ahmed, Mohamed Chen, Evan Zambrano, Hector Bradshaw, Danielle Mercadal, Santiago Schwartz, Marc Tracy, Sean Dholaria, Bhagirathbhai Kubiak, Michal Mukherjee, Akash Majhail, Navneet Battiwalla, Minoo Mountjoy, Luke Malik, Shahbaz A. Mathews, John Shaughnessy, Paul Logan, Aaron C. Ladha, Abdullah Stefan, Maryann Guzowski, Caitlin Hoeg, Rasmus T. Hilal, Talal Moore, Jozal Connor, Matthew O'Dwyer, Kristen M. Hill, LaQuisa C. Tsai, Stephanie B. Sasine, Joshua Solh, Melhem M. Lee, Catherine J. Kota, Vamsi K. Koura, Divya Veeraputhiran, Muthu Blunk, Betsy Oliai, Caspian Leonard, Jessica T. Frey, Noelle V. Park, Jae H. Luskin, Marlise R. Bachanova, Veronika Galal, Ahmed Bishop, Michael R. Stock, Wendy Cassaday, Ryan D. Pullarkat, Vinod Shah, Bijal D. Muffly, Lori S.